XTX Topco’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.69M Buy
116,135
+20,029
+21% +$593K 0.05% 579
2026
Q1
$2.9M Buy
96,106
+74,115
+337% +$2.4M 0.05% 580
2025
Q4
$763K Buy
+21,991
New +$776K 0.02% 1237
2025
Q3
Sell
-20,873
Closed -$655K 2874
2025
Q2
$655K Buy
20,873
+2,681
+15% +$83.3K 0.03% 926
2025
Q1
$540K Sell
18,192
-704
-4% -$21.1K 0.03% 977
2024
Q4
$557K Buy
18,896
+3,437
+22% +$109K 0.05% 681
2024
Q3
$481K Buy
15,459
+6,516
+73% +$237K 0.03% 844
2024
Q2
$303K Buy
+8,943
New +$456K 0.03% 956

Other funds holding IMCR

XTX Topco's IMCR Position: Q2 2026 in Review

XTX Topco increased its Immunocore (IMCR) stake by 21% in Q2 2026, buying an estimated $593K and bringing the position to 116,135 shares worth $3.69M. The position accounts for 0.05% of the portfolio, ranked #579.

XTX Topco first reported a position in IMCR in Q2 2024 and has held it in 8 quarters since. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • XTX Topco held 116,135 shares of Immunocore worth $3.69M as of Q2 2026.
  • XTX Topco bought 20,029 Immunocore shares in Q2 2026, an estimated $593K.
  • Immunocore made up 0.05% of XTX Topco's portfolio in Q2 2026, its #579 holding.
  • XTX Topco first reported a position in Immunocore in Q2 2024 and has held it in 8 quarters since.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.